Body mass index and disease activity at treatment initiation: Potential new predictors of response to azathioprine therapy in IBD

Inflammatory Bowel Diseases

Volumn 16, Issue 4, 2010, Pages 714-715

  Sokol, Harry ^a   Beaugerie, Laurent ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; ENEMA;

BODY MASS; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENTERITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NOTE; PREDICTION; PRIORITY JOURNAL; REMISSION; TREATMENT RESPONSE; ULCERATIVE COLITIS;

EID: 77949502979     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21102     Document Type: Note

References (11)

1. Batra A, Zeitz M, Siegmund B. Adipokine signaling in inflammatory bowel disease. Inflamm Bowel Dis. 2009 [Epub ahead of print].
2. Desreumaux P, Ernst O, Geboes K, et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology. 1999;117:73-81.
3. Hass DJ, Brensinger CM, Lewis JD, et al. The impact of increased body mass index on the clinical course of Crohn's disease. Clin Gastroenterol Hepatol. 2006;4:482-488.
4. Blain A, Cattan S, Beaugerie L, et al. Crohn's disease clinical course and severity in obese patients. Clin Nutr. 2002;21:51-57.
5. Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006;354:54-66.
6. D'Haens G, Baert F, van Assche G, et al. Early combined immuno-suppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet. 2008;371: 660-667.
7. Cosnes J, Nion-Larmurier I, Beaugerie L, et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut. 2005;54:237-241.
8. Picco MF, Zubiaurre I, Adluni M, et al. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease. Am J Gastroenterol. 2009 [Epub ahead of print].
9. Vernier-Massouille G, Balde M, Salleron J, et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology. 2008;135:1106-1113.
10. Sokol H, Seksik P, Nion-Larmurier I, et al. Current smoking, not duration of remission, delays Crohn's disease relapse following azathioprine withdrawal. Inflamm Bowel Dis. 2009 [Epub ahead of print].
11. Treton X, Bouhnik Y, Mary JY, et al. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse. Clin Gastroenterol Hepatol. 2009;7:80-85.